Study demonstrates LpxT's role in controlling polymyxin B resistance in Pseudomonas aeruginosa, suggesting pathways for new treatments.
Treatment of Pseudomonas aeruginosa infections is challenging due to its antibiotic resistance. Polymyxins are considered last-resort options for treating serious infections caused by multidrug-resistant P. aeruginosa. Understanding the molecular mechanisms of polymyxin resistance may provide clues for the development of new therapeutic strategies against P. aeruginosa. In this study, we demonstrated that the phosphatidic acid-phosphatase family (PAP2) protein LpxT interacts with L-Ara4N transferase ArnT and controls polymyxin B resistance in P. aeruginosa. Our findings reveal a novel role for lpxT and its molecular mechanism to defend against polymyxin B in P. aeruginosa.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: